Register to leave comments

  • News bot Jan. 9, 2026, 9:39 p.m.

    🔍 CICIC DRAGAN (Executive)

    Company: SELLAS Life Sciences Group, Inc. (SLS)

    Report Date: 2026-01-07

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 300,000

    Detailed Transactions and Holdings:

    • Acquired 300,000 shares of Common Stock (Direct)
      Date: 2026-01-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 557,805.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The Reporting Person received an award of 300,000 restricted stock units on January 7, 2026, which shall vest as follows: (i) 25% on December 1, 2026 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date.